FindTrial
Sign In

Interferon-beta

DRUG4 trials

Sponsors

Biogen, Fundació Institut Germans Trias i Pujol, Central Hospital, Nancy, France, Population Health Research Institute

Conditions

Anaplastic AstrocytomaCoronavirusGlioblastoma MultiformeGliosarcomaMultiple SclerosisMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis, Relapsing-RemittingOligoastrocytoma, Mixed

Phase 1

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
CompletedNCT00031083
BiogenAnaplastic Astrocytoma, Glioblastoma Multiforme, Gliosarcoma +1
Start: 2002-04-02End: 2003-10-10Target: 12Updated: 2020-11-17
Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)
NCT02903537
Fundació Institut Germans Trias i PujolMultiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting
Start: 2017-07-06End: 2023-12-31Target: 16Updated: 2023-07-07

Phase 3

Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial
CompletedNCT04324463
Population Health Research InstituteCoronavirus, Severe Acute Respiratory Syndrome
Start: 2020-04-21End: 2022-12-30Updated: 2024-01-11

Unknown Phase

Multiple Sclerosis: Chi3L1 and Treatment Efficacy
CompletedNCT04289675
Central Hospital, Nancy, FranceMultiple Sclerosis
Start: 2012-01-01End: 2019-12-01Updated: 2020-03-09

Related Papers

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis
BMJ Open2024-09-018 citations
Abstracts from the 37th Annual Meeting of the Consortium of Multiple Sclerosis Centers: May 31-June 3, 2023 · Aurora, Colorado
International Journal of MS Care2023-05-01
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
2022-10-1022 citations
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
2022-10-1020 citations
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry
International Journal of Clinical Practice2022-01-015 citations
Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19
JAMA Network Open2021-12-2935 citations
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
BMJ Open2019-09-0197 citations